- Investing Ideas
- Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
CSPC Innovation Pharmaceutical
Market Cap: CN¥58.0b
Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.
300765
CN¥41.45
7D
10.9%
1Y
-21.1%
AcrobiosystemsLtd
Market Cap: CN¥8.8b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥51.80
7D
-2.8%
1Y
-0.4%